References

1. 1.
   VOGEL B，CLAESSEN B E，ARNOLD S V，et al.ST-segment elevation myocardial infarction［J］.Nat Rev Dis Primers，2019，5（1）：39.
2. 2.
   DONG L，JIANG X Q.Research progress on the pathogenesis and diagnosis and treatment of acute myocardial infarction［J］.J Shandong First Med Univ&Shandong Acad Med Sci，2021，42（6）：476-480.
3. 3.
   LIU M B，HE X Y，YANG X H，et al.Interpretation of Report on Cardiovascular Health and Diseases in China 2023［J］.Chin Gen Prac，2025，28（1）：20-38.
4. 4.
   The Writing Committee of the Report on Cardiovascular Health and Diseases in China.Report on cardiovascular health and diseases in China 2022：An updated summary［J］.Chin Circul J，2023，38（6）：583-612.
5. 5.
   YANG H，XIAO Y，LI Y Q，et al.Research progress in the treatment of acute myocardial infarction with traditional Chinese medicine［J］.J North China Univ Sci and Tec （Med Edit），2019，21（5）：403-406，420.
6. 6.
   REED G W，ROSSI J E，CANNON C P.Acute myocardial infarction［J］.Lancet，2017，389（10065）：197-210.
7. 7.
   DUAN T B，XIANG D C.Research progress on the occurrence mechanism and treatment methods of coronary microcirculation obstruction after acute myocardial infarction［J］.Chin Circul J，2019，34（7）：722-725.
8. 8.
   ZHONG Y，WANG Z X.Research progress on the treatment of heart failure after acute myocardial infarction with Chinese medicine［J］.Basic Tradit Chin Med，2024，3（2）：119-124.
9. 9.
   WU C，WANG F R.Research progress on acute myocardial infarction-induced heart failure from the perspective of both traditional Chinese medicine and western medicine［J］.Adv Clin Med，2024，14（5）：1466-1474.
10. 10.
    LI P，LI Y，JIN J L，et al.Visualization analysis of research hotspots and trends on coronary heart disease Chinese syndrome based on CiteSpace［J］.Tianjin J Tradit Chin Med，2024，41（8）：1012-1017.
11. 11.
    DUAN W H，LI L Z，WANG C L，et al.Research on the distribution of Chinese syndrome and its correlation with cardiac function in acute myocardial infarction［J］.Beijing J Tradit Chin Med，2010，29（4）：243-245.
12. 12.
    CUI L H，GUO S W.Analysis of the characteristics of 9326 cases of myocardial infarction from the perspective of Chinese syndrome［J］.J Tradit Chin Med，2018，46（1）：23-27.
13. 13.
    NAZEM M R，BASTANHAGH E，EMAMI A，et al.The relationship between thyroid function tests and sleep quality：Cross-sectional study［J］.Sleep Sci，2021，14（3）：196-200.
14. 14.
    HIBI M，KUBOTA C，MIZUNO T，et al.Effect of shortened sleep on energy expenditure，core body temperature，and appetite：A human randomised crossover trial［J］.Sci Rep，2017，7：39640.
15. 15.
    LIU T，WANG W，ZHAO M J，et al.Establishment of a rat myocardial infarction model by ligation of the left anterior descending coronary artery［J］.Lab Anim Comp Med，2009，29（2）：120-123.
16. 16.
    DIAO H Q，Z J，W M，et al.Application and evaluation of modified multi-platform water environment method in sleep deprivation animal model［J］.Acta Lab Anim Sci Sin，2023，31（1）：120-128.
17. 17.
    YANG Q，ZHANG Y O，JIA L L，et al.Establishment of rat myocardial infarction model and evaluation of disease progression［J］.CJTER，2022，26（23）：3733-3737.
18. 18.
    ANDERSON J L，MORROW D A.Acute myocardial infarction［J］.N Engl J Med，2017，376（21）：2053-2064.
19. 19.
    FANG Y，SUN Y，JIAN J.Protective effects of Bauhinia championii flavones on pituitrin-inducedacute myocardial ischemia in rats［J］.Chin Pharmacol Bull，2013，29（11）：1592-1596.
20. 20.
    KOUDSTAAL S，JANSEN S，GHO J M I H，et al.Myocardial infarction and functional outcome assessment in pigs［J］.J Vis Exp，2014，25（86）：51269.
21. 21.
    WANG H J，TAN Y Z.Establishment and application of animal models of myocardial infarction［J］.Acta Anat Sin，2024，55（2）：247-252.
22. 22.
    HUANG S，REN J X，WANG S C，et al.Establishment of rat model of coronary heart disease with Qi deficiency and blood stasis syndrome［J］.China J Chin Mater Med，2016，41（9）：1699-1705.
23. 23.
    CAO J，LI Y K，CHEN M Q，et al.Research progress on methods of preparing rat model of acute myocardial infarction［J］.Chin J Comp Med，2017，27（10）：96-100.
24. 24.
    PENG S H，XIE C G，GAO H，et al.Brief introduction to Qi-Yin deficiency syndrome［J］.Sichuan J Tradit Chin Med，2019，37（10）：219-221.
25. 25.
    LI C，WANG S K，SI H B.Research progress on methods of establishing Qi deficiency syndrome animal model［J］.Prog Vet Med，2018，39（9）：92-95.
26. 26.
    FU X L，FANG Z Q.Modeling methods and appraisal of Yin-deficiency syndrome in animals［J］.Acade J Shanghai Univ Tradit Chin Med，2004，18（2）：51-54.
27. 27.
    DING S，GAO C J，LU F，et al.Comparison of methods for preparing two mouse models of Qi-Yin deficiency syndrome［J］.J Tradit Chin Med，2023，64（4）：401-409.
28. 28.
    GAO Y X，ZHANG Q Y，PENG J Q，et al.Construction and evaluation of animal model of Qi-Yin deficiency syndrome in acute myocardial infarction of coronary heart disease［J］.Chin J Exp Tradit Med Form，2024，30（4）：134-142.
29. 29.
    SHI Y，GUO J C，XUN Y H.Analysis of establishment methods and thinking of animal models of Yin deficiency syndrome［J］.Chin Arch Tradit Chin Med，2017，35（3）：725-727.
30. 30.
    ZHAO G R，MAO Y N，CHEN Y Y，et al.Exploration on correlation of spleen-stomach and diet from classic Chinese medicine［J］.J Hunan Univ Chin Med，2015，35（12）：40-42.
31. 31.
    LI X H，TAN Q H.Research progress on the relationship between food intolerance and functional gastrointestinal disorders［J］.World Chin J Digestol，2013，21（25）：2551-2556.
32. 32.
    WANG S J.Investigation and analysis of the causes of coronary heart disease and preventive guidance［J］.J North China Coal Med Univ，2003，5（4）：435-435.
33. 33.
    SANG D，LIN K，YANG Y，et al.Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals［J］.Cell，2023，186（25）：5500-5516.
34. 34.
    YIN J，SONG Y Q，PAN Y，et al.Discussion on the evaluation criteria of coronary heart disease Qi-Yin deficiency syndrome animal model based on clinical literature［J］.Chin Tradit Herb Drugs，2017，48（4）：798-802.
35. 35.
    YAP J，IREI J，LOZANO-GERONA J，et al.Macrophages in cardiac remodelling after myocardial infarction［J］.Nat Rev Cardiol，2023，20（6）：373-385.
36. 36.
    FRANGOGIANNIS N G.The inflammatory response in myocardial injury，repair，and remodelling［J］.Nat Rev Cardiol，2014，11（5）：255-265.
37. 37.
    MILLS K H G.IL-17 and IL-17-producing cells in protection versus pathology［J］.Nat Rev Immunol，2023，23（1）：38-54.
38. 38.
    CLEARE A J.The HPA axis and the genesis of chronic fatigue syndrome［J］.Trends Endocrinol Metab，2004，15（2）：55-59.
39. 39.
    XIAO Q Q，GAO J，HE L C，et al.Effect of Tianwang Buxin pill on HPA axis-related hormones and receptor gene expression in widespread anxiety with Yin deficiency rats［J］.Liaoning J Tradit Chin Med，2019，46（6）：1137-1142.
40. 40.
    KARGA H，GIAGOURTA I，PAPAIOANNOU G，et al.Transient changes in thyroid functions tests after zoledronic acid infusion［J］.Endocr J，2011，58（11）：969-977.
41. 41.
    LU R L，XU R J.Correlation between Yin-Yang deficiency syndrome and pituitary-thyroid axis in type 2 diabetes mellitus［J］.West Chin Med，2017，30 （3） ：93-95.
42. 42.
    WANG X，DU Y，WU C，et al.UHPLC-MS/MS analysis of cAMP and cGMP in rat plasma as potential biomarkers of Yin-Yang disharmony in traditional Chinese medicine［J］.J Pharm Anal，2021，11（4）：458-464.
43. 43.
    MA L，WANG J F.Exploring the quantitative indicators of Yin and Yang in six branch classification based on the distribution and ratio of cAMP and cGMP［J］.Chin J Integr Med，2017，9（27）：4-6.
44. 44.
    WANG S，BAI M，MIAO M S.Diagnostic indicators and analysis of the animal model of Yin deficiency syndrome［J］.Chin J Comp Med，2021，31（1）：132-137.